메뉴 건너뛰기




Volumn 364, Issue 9438, 2004, Pages 917-918

Can the genotoxicity of chemotherapy be predicted?

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE INHIBITOR; HEMOPOIETIC GROWTH FACTOR; MERCAPTOPURINE;

EID: 4444372450     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17038-4     Document Type: Note
Times cited : (6)

References (10)
  • 3
    • 3042781653 scopus 로고    scopus 로고
    • Genotoxicity of therapeutic intervention in children with acute lymphocytic leukemia
    • Rice SC, Vacek P, Homans AH, et al. Genotoxicity of therapeutic intervention in children with acute lymphocytic leukemia. Cancer Res. 64:2004;4464-4471
    • (2004) Cancer Res , vol.64 , pp. 4464-4471
    • Rice, S.C.1    Vacek, P.2    Homans, A.H.3
  • 4
    • 0032501167 scopus 로고    scopus 로고
    • The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy
    • Fuscoe JC, Knapp GW, Hanley NM, et al. The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy. Mutat Res. 419:1998;107-121
    • (1998) Mutat Res , vol.419 , pp. 107-121
    • Fuscoe, J.C.1    Knapp, G.W.2    Hanley, N.M.3
  • 6
    • 0035906222 scopus 로고    scopus 로고
    • Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study
    • Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 93:2001;618-629
    • (2001) J Natl Cancer Inst , vol.93 , pp. 618-629
    • Neglia, J.P.1    Friedman, D.L.2    Yasui, Y.3
  • 7
    • 0034034557 scopus 로고    scopus 로고
    • Topoisomerase II inhibitor-related acute myeloid leukaemia
    • Pui CH, Relling MV. Topoisomerase II inhibitor-related acute myeloid leukaemia. Br J Haematol. 109:2000;13-23
    • (2000) Br J Haematol , vol.109 , pp. 13-23
    • Pui, C.H.1    Relling, M.V.2
  • 8
    • 2642570170 scopus 로고    scopus 로고
    • Moving towards individualized medicine with pharmacogenomics
    • Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature. 429:2004;464-468
    • (2004) Nature , vol.429 , pp. 464-468
    • Evans, W.E.1    Relling, M.V.2
  • 9
    • 0036488604 scopus 로고    scopus 로고
    • Second cancer in survivors of childhood cancer
    • Bhatia S, Sklar C. Second cancer in survivors of childhood cancer. Nat Rev Cancer. 2:2002;124-132
    • (2002) Nat Rev Cancer , vol.2 , pp. 124-132
    • Bhatia, S.1    Sklar, C.2
  • 10
    • 19044399684 scopus 로고    scopus 로고
    • Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
    • Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 1:2002;133-143
    • (2002) Cancer Cell , vol.1 , pp. 133-143
    • Yeoh, E.J.1    Ross, M.E.2    Shurtleff, S.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.